Generics - Pharmaceutical, Diabetes

Filter

Current filters:

PharmaceuticalDiabetes

Popular Filters

$200+ billion annual opportunity in USA from using medicines more responsibly, IMS finds

20-06-2013

Avoidable costs of more than $200 billion are incurred each year in the US health care system as a result…

Antibiotics and Infectious diseasesDiabetesFinancialGenericsHealthcareNorth AmericaPharmaceutical

Negative US patent ruling for Novo Nordisk on Prandin

19-06-2013

Denmark-based insulin giant Novo Nordisk (NOV: N) says that the US Court of Appeals for the Federal Circuit…

DiabetesGenericsLegalNovo NordiskPatentsPharmaceuticalPrandin

Mylan settles with Shionogi and Andrx over Fortamet; Merck & Co diagnostics deal with Luminex

14-03-2013

US generic drugmaker Mylan (Nasdaq: MYL) has entered into a settlement agreement with Japan's Shionogi…

AndrxDiabetesFortametGenericsLuminexMerck & CoMylan LaboratoriesNeurologicalNorth AmericaPatentsPharmaceuticalShionogi

Brazil interested in investing $4.5 Billion in Ukraine, including pharma

19-11-2012

Brazil has submitted to Ukrainian authorities $4.5 billion worth of investment proposals. "We want to…

DiabetesEuropeFinancialGenericsPharmaceuticalProductionSouth America

Shire's Dermagraft cleared in Canada; settles Intuniv litigation

06-09-2012

Ireland headquartered Shire (LSE: SHP), NASDAQ: SHPG) says that its lead regenerative medicine product,…

Anchen PharmaceuticalsDermagraftDermatologicalsDiabetesGenericsIntunivNeurologicalNorth AmericaPatentsPharmaceuticalRegulationShireTWi Pharmaceuticals

Depomed to file NDA for Serada; with Valeant sues Watson over Glumetza

20-04-2012

US drugmaker Depomed (Nasdaq: DEPO) says that it has completed a Type B pre-New Drug Application meeting…

DepomedDiabetesGenericsGlumetzaNorth AmericaPatentsPharmaceuticalRegulationResearchSeradaValeant PharmaceuticalsWatson PharmaceuticalsWomen's Health

US Supreme Court ruling in Novo Nordisk Prandin case favors generic drugmakers

18-04-2012

The US Supreme Court yesterday reversed the US Court of Appeals for the Federal Circuit's April 2010…

Caraco PharmaceuticalDiabetesGenericsLegalNorth AmericaNovo NordiskPatentsPharmaceuticalPrandiMetPrandinrepaglinideSun Pharmaceutical Industries

New Actavis/Bioton alliance aims to shake up diabetes market

31-01-2012

Icelandic generics drugmaker Actavis and Poland’s Bioton (WSE: BIO) have formed a joint venture…

ActavisBiotonDiabetesGenericsMarkets & MarketingMergers & AcquisitionsPharmaceutical

Back to top